Biotech Wheeling And Dealing
Biotech stocks are all the rage right now – and within the biotech sector, deals are all the rage. Here’s a look at recent investments,… Read More »Biotech Wheeling And Dealing
Invest
“Billionaire-Loved Dividend Dogs”
Given the resources at their disposal and their intimate connections to insiders and others, it’s not a bad idea to study which stocks billionaires are… Read More »“Billionaire-Loved Dividend Dogs”
“Solid Total Return Potential”: 5 Tech Stocks For Conservative Growth Investors
With higher dividend yields than the S&P 500 and outstanding metrics, these five quality tech stocks offer conservative growth investors solid total return potential with… Read More »“Solid Total Return Potential”: 5 Tech Stocks For Conservative Growth Investors
The (Limited?) Good News And (Much?) Bad News For Stocks In The Biden Era
Looking ahead to the start of the Biden administration, stocks have two things going for them: historical post-election trends and an accommodating Federal Reserve. But… Read More »The (Limited?) Good News And (Much?) Bad News For Stocks In The Biden Era
This Biotech ETF Has “Clinical Trial Potency”
Independent of what happens on the coronavirus vaccine front, there could be big upside in store in 2021 for this biotech ETF, whose small- and… Read More »This Biotech ETF Has “Clinical Trial Potency”
Small-Caps’ Big Potential
Small-cap stocks have been rallying. And with small-caps currently trading at the biggest discount to their large-cap counterparts in about 20 years – and the… Read More »Small-Caps’ Big Potential
4 Dividend Stocks Offering Value And 100%+ Growth
These four dividend-paying stocks offer growth above 100% this year – and shares of each are currently undervalued. CLICK HERE.
The Distinguished Dozen That Have Reliably Beaten The Market
It’s no easy feat to reliably beat the S&P 500, but twelve stocks have managed to outperform the benchmark for each of the past five… Read More »The Distinguished Dozen That Have Reliably Beaten The Market
The Key Number To Study In Vaccine Study Results
Whether it’s for COVID-19 or any other disease or disorder, there’s one key number that investors need to focus on when it comes to study… Read More »The Key Number To Study In Vaccine Study Results
An Ideal Strategy For MedTech
While the deferral of elective medical/surgical procedures amid the coronavirus crisis has hit a number of MedTech names hard, there are also some fundamentally strong… Read More »An Ideal Strategy For MedTech